Search

everythinglearnresearchcommunity

for

Search:↓

The article concludes that better understanding gene regulation related to seasonal changes can offer insights into the mechanisms of seasonal timing in mammals.

Benzodiazepines changed hormone levels but did not affect hair growth in women with idiopathic hirsutism.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Dihydrotestosterone changes some hormone-related gene expressions in rat pituitary glands but doesn't affect the estrous cycle.

The testes produce important hormones like testosterone and others that play key roles in male body functions.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

Thyrotropin-releasing hormone may help control skin and hair growth and could aid in treating related disorders.

Growth hormone is important for regulating human hair growth.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Low zinc and selenium levels in sheep are linked to hair loss and thyroid problems.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

Stress hormone CRF can cause hair loss by affecting hair growth cells and hormones.

Women with PCOS, especially if they are obese, are more likely to have an underactive thyroid than women without PCOS.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

AMH levels in adolescents with PCOS are not affected by their weight.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

More research is needed to understand how testosterone is maintained in adult males.

Laparoscopic ovarian drilling helps infertile women with PCOS by improving menstrual regularity, ovulation, and chances of conception, and by changing hormone levels.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

High Nesfatin-1 and low Vitamin D may increase blood pressure and heart rate in women with PCOS.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.